Feb 12, 2020 InVivo Therapeutics Holdings Corp. NVIV 1.66 0.13 (8.61%). NASDAQ Updated Jun 4, 2020 11:59 PM Novus Therapeutics Inc. NVUS 0.53 0.00 (0.00%). NASDAQ Updated Jun 8, 2020 6:34 PM InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) today announced the closing of its previously announced public offering of 2,545,455 shares of common stock (or pre-funded warrants to purchase Its clinical development program is the Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a
InVivo Therapeutics Holdings Corp Common Stock (NVIV ... Jun 21, 2018 Stock Picks, Stock Market Investing | Seeking Alpha
Jun 21, 2018
NVIV: InVivo Therapeutics Holdings Corp - Brokerage ... NVIV: InVivo Therapeutics Holdings Corp broker recommendations. Get the latest broker recommendations from Zacks Investment Research.
NVIV -- Is Its Stock Price A Worthy Investment? Learn More.